False-positive HIV-1 virus cultures using whole blood. 1992

J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik

UI MeSH Term Description Entries
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
August 1993, AIDS (London, England),
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
August 2000, Clinical pediatrics,
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
January 1993, Lancet (London, England),
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
November 1976, JAMA,
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
August 1977, American journal of epidemiology,
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
January 2020, Indian journal of medical microbiology,
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
October 1982, MMWR. Morbidity and mortality weekly report,
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
January 2013, Human vaccines & immunotherapeutics,
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
February 1988, Lancet (London, England),
J Schüpbach, and J B Jendis, and C Bron, and J Böni, and Z Tomasik
March 1988, Lancet (London, England),
Copied contents to your clipboard!